SaaS
Doubling Xevant’s Share of Voice and Disrupting Healthcare Norms
Industry
Recognition
35
Media Placements
Doubled
Share of Voice
THE
CHALLENGE
Xevant—a tech disruptor in the pharmacy benefits management (PBM) space—faced a steep uphill climb. Despite its groundbreaking platform automating real-time data analysis and driving transparency, Xevant was barely a blip on the industry radar. Its share of voice (SOV) in the PBM conversation? A mere 2%. Competitors were dominating the narrative, leaving Xevant’s innovative solutions in the shadows.
The task was clear: amplify Xevant’s presence, establish it as the voice of authority in the PBM sector, and position the brand as the solution to the industry’s most pressing challenges.
THE
SOCIETY22
APPROACH
When others zig, Society22 zags. We knew Xevant didn’t just need more visibility—it needed dominance. Here’s how we made it happen:
Reading the Room—and Owning It
The healthcare sector is volatile. Legislative shake-ups, drug shortages, and pharmacy labor strikes are daily headlines. Society22 kept a finger on the pulse, identifying exactly where Xevant could insert its expertise into conversations shaping the industry.
Building a Powerhouse of Authority
Thought leaders don’t just participate in the conversation; they lead it. We positioned Xevant’s team as industry experts by crafting high-impact bylines, commentary, and pitches that hit home in outlets like Entrepreneur, MedCity News, and Drug Topics.
Broadening the Stage
To ensure Xevant wasn’t just preaching to the choir, we secured placements beyond industry niches, landing features across podcasts, digital platforms, and high-profile news outlets. This strategy extended Xevant’s reach to policymakers, consumers, and decision-makers alike.
Creating Content That Converts
From launching an authoritative eBook to leading insightful webinars, we ensured Xevant’s content was more than just noise. It was actionable, compelling, and laser-focused on the pain points plaguing the PBM world.
Amplifying the Brand Through Recognition
Big players get noticed at big stages. Society22 got Xevant invitations to powerhouse events like the Forbes Healthcare Summit and earned them speaking roles that put them front and center.
Ready to write your
success story?
THE
RESULTS
When the dust settled, the numbers spoke for themselves:
SOV Growth: In just five months, Xevant doubled its share of voice to 4%. That’s a leap competitors couldn’t ignore.
Media Impact: Mentions skyrocketed from 592 to over 1,100, with placements spanning industry heavyweights like Wall Street Journal, MedCity News, and US Reporter
Consistent Wins: Averaging six successful media hits per month, we racked up 35 placements total—each one sharpening Xevant’s edge in the market.
Thought Leadership in Action: Speaking engagements at premier events and recognitions like invitations to the Forbes Business Council solidified Xevant as a trusted name in healthcare innovation.
THE
IMPACT
Today, Xevant isn’t just part of the healthcare conversation—it’s setting the agenda. With a bolstered SOV, expanded audience, and undeniable industry credibility, Xevant is primed for its next chapter: a funding round that will further cement its market dominance.
At Society22, we help clients redefine the rules of the game. For Xevant, that meant transforming a 2% whisper into a commanding voice that’s shaping the future of PBM. Bold moves deliver bold results—and we’re just getting started.
Ready to write your success story?
Connect with Society22 Today.